Company Filing History:
Years Active: 2012-2017
Title: Innovations and Contributions of Inventor Bryan P. Toole
Introduction
Bryan P. Toole is a notable inventor based in Mt. Pleasant, SC, who has made significant contributions to the field of biomedical research. He holds three patents that focus on innovative methods for treating airway diseases and addressing multi-drug resistance in cancer therapy. His work has implications for improving patient outcomes in respiratory and oncological conditions.
Latest Patents
One of Toole's latest patents is titled "Uses of antagonists of hyaluronan signaling." This patent describes the discovery that hyaluronan antagonists, which inhibit hyaluronan signaling, can effectively reduce airway inflammation and hyperresponsiveness. The patent outlines methods for preventing or treating airway diseases by administering these antagonists, which may include heparosan and hyaluronan oligosaccharides. Another significant patent is "Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers." This patent provides pharmaceutical compositions and methods aimed at sensitizing multi-drug resistant cancer cells to chemotherapeutic agents, utilizing ligands of hyaluronan receptors and various derivatives.
Career Highlights
Throughout his career, Bryan P. Toole has worked with prestigious institutions such as Tufts University and the National Institutes of Health, which is a component of the U.S. Department of Health & Human Services. His research has focused on the intersection of biochemistry and medicine, leading to advancements in therapeutic strategies.
Collaborations
Toole has collaborated with esteemed colleagues, including Suniti Misra and Shibnath Ghatak, contributing to a rich exchange of ideas and research findings in his field.
Conclusion
Bryan P. Toole's innovative work and patents reflect his commitment to advancing medical science and improving treatment options for patients. His contributions are vital in the ongoing fight against airway diseases and cancer.